Palatin Technologies Inc (PTN) - Total Assets
Based on the latest financial reports, Palatin Technologies Inc (PTN) holds total assets worth $3.73 Million USD as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Palatin Technologies Inc - Total Assets Trend (1996–2024)
This chart illustrates how Palatin Technologies Inc's total assets have evolved over time, based on quarterly financial data. Also see PTN market cap overview for the company's overall valuation and market capitalisation.
Palatin Technologies Inc - Asset Composition Analysis
Current Asset Composition (June 2024)
Palatin Technologies Inc's total assets of $3.73 Million consist of 91.0% current assets and 9.1% non-current assets. Review PTN total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 88.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2024)
This chart illustrates how Palatin Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Palatin Technologies Inc (PTN) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Palatin Technologies Inc's current assets represent 91.0% of total assets in 2024, a decrease from 97.5% in 1996.
- Cash Position: Cash and equivalents constituted 88.7% of total assets in 2024, down from 96.5% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1996.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Palatin Technologies Inc Competitors by Total Assets
Key competitors of Palatin Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ALK-Abelló A/S
CO:ALK-B
|
Denmark | Dkr9.17 Billion |
|
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
|
USA | $890.92 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF3.09 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Nanobiotix
NASDAQ:NBTX
|
USA | $67.76 Million |
|
Inhibrx Biosciences, Inc.
NASDAQ:INBX
|
USA | $183.97 Million |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
Palatin Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.32 | 1.20 | 21.28 |
| Quick Ratio | 0.32 | 1.20 | 21.28 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.82 Million | $1.74 Million | $79.66 Million |
Palatin Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Palatin Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.83 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | -40.1% |
| Total Assets | $10.74 Million |
| Market Capitalization | $2.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values Palatin Technologies Inc's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Palatin Technologies Inc's assets decreased by 40.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Palatin Technologies Inc (1996–2024)
The table below shows the annual total assets of Palatin Technologies Inc from 1996 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | $10.74 Million | -40.12% |
| 2023-06-30 | $17.94 Million | -50.27% |
| 2022-06-30 | $36.07 Million | -46.40% |
| 2021-06-30 | $67.30 Million | -20.88% |
| 2020-06-30 | $85.05 Million | -18.79% |
| 2019-06-30 | $104.74 Million | +168.44% |
| 2018-06-30 | $39.02 Million | -31.35% |
| 2017-06-30 | $56.83 Million | +414.25% |
| 2016-06-30 | $11.05 Million | -62.50% |
| 2015-06-30 | $29.47 Million | +134.69% |
| 2014-06-30 | $12.56 Million | -49.91% |
| 2013-06-30 | $25.07 Million | +366.02% |
| 2012-06-30 | $5.38 Million | -74.59% |
| 2011-06-30 | $21.17 Million | +70.90% |
| 2010-06-30 | $12.39 Million | -6.14% |
| 2009-06-30 | $13.20 Million | -30.98% |
| 2008-06-30 | $19.12 Million | -55.30% |
| 2007-06-30 | $42.78 Million | +6.83% |
| 2006-06-30 | $40.05 Million | +13.88% |
| 2005-06-30 | $35.17 Million | +44.25% |
| 2004-06-30 | $24.38 Million | +7.30% |
| 2003-06-30 | $22.72 Million | +83.85% |
| 2002-06-30 | $12.36 Million | -13.24% |
| 2001-06-30 | $14.24 Million | +60.31% |
| 2000-06-30 | $8.89 Million | +89.05% |
| 1999-06-30 | $4.70 Million | -27.69% |
| 1998-06-30 | $6.50 Million | -53.90% |
| 1997-06-30 | $14.10 Million | +100.25% |
| 1996-06-30 | $7.04 Million | -- |
About Palatin Technologies Inc
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is… Read more